These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 27907813

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Olivier CB, Weik P, Meyer M, Weber S, Anto-Michel N, Diehl P, Zhou Q, Geisen U, Bode C, Moser M.
    Thromb Res; 2016 Feb; 138():63-68. PubMed ID: 26610745
    [Abstract] [Full Text] [Related]

  • 3. Enhanced TRAP-induced platelet aggregation with dabigatran - Clinical perspective.
    Bhagirath VC, Bosch J, Eikelboom JW.
    Thromb Res; 2016 Feb; 138():61-62. PubMed ID: 26757599
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J, Inoue N, Otsui K, Ishii H, Gorog DA.
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [Abstract] [Full Text] [Related]

  • 6. Thrombin-induced platelet aggregation -effect of dabigatran using automated platelet aggregometry.
    Shimizu M, Natori T, Tsuda K, Yoshida M, Kamada A, Oi K, Ishigaku Y, Oura K, Narumi S, Yamamoto M, Terayama Y.
    Platelets; 2020 May; 31(3):360-364. PubMed ID: 31161848
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Triple antiplatelet therapy in obese patients undergoing stent implantation.
    Balta S, Demirkol S, Celik T, Unlu M, Arslan Z, Haqmal H.
    Angiology; 2013 Oct; 64(7):559-60. PubMed ID: 23478449
    [No Abstract] [Full Text] [Related]

  • 14. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M.
    Acta Pol Pharm; 2009 Oct; 66(3):235-42. PubMed ID: 19645323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M, Marchetti M, Russo L, Tartari CJ, Leuzzi A, Finazzi G, Rambaldi A, ten Cate H, Falanga A.
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models.
    Li YZ, Gong GQ, Yang WH, Wang XH, Jiang ML, Zhou Y, Yang XZ, Xu YG, He GW.
    Thromb Res; 2013 May; 131(5):425-35. PubMed ID: 23535565
    [Abstract] [Full Text] [Related]

  • 19. Proceedings of the Third Freiburg Thrombosis Meeting.
    Duerschmied D.
    Hamostaseologie; 2018 Nov; 38(4):183-185. PubMed ID: 30500968
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.